Product Overview

• 3-(2-Chloroethyl)-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one hydrochloride is a highly advanced bicyclic heterocyclic pharmaceutical intermediate compound. It is commercially supplied as an off-white to light beige crystalline solid powder featuring high physical stability. ProCorBay International supplies premium technical-grade blocks to global active ingredient manufacturing lines requiring exceptional molecular assays and low moisture parameters.
• This compound is manufactured via multi-step organic coupling platforms, typically involving the condensation of 2-aminopyridine derivatives with specialized acetylbutyrolactone matrices, followed by ring hydrogenation, chlorination of the hydroxyl branch, and subsequent salt conversion into its hydrochloride form to maximize crystalline shelf life. ProCorBay sources this chemical block from advanced heterocyclic synthesis operations tracking strict organic volatile residues and heavy metal impurity profiles.
• Within modern life sciences and psychiatric healthcare manufacturing, this pyridopyrimidine nucleus functions as a vital structural predecessor and key advanced intermediate. It acts as the direct regulatory structural predecessor and synthetic cornerstone for manufacturing blockbuster atypical antipsychotic medications—most notably serving as the core synthetic platform for compiling Risperidone, Paliperidone, and Paliperidone Palmitate. The localized terminal chloroethyl aliphatic string provides an exceptional highly reactive node for executing selective nucleophilic amine substitution loops, allowing developers to couple the pyridopyrimidine core smoothly with substituted piperidine chains. ProCorBay functions as a reliable bulk partner, delivering extensive technical dossiers to ensure smooth production pipelines.